Head and Neck Cancer Surgery Triage Guidelines During the COVID-19 Pandemic

Multidisciplinary consensus guidelines for triaging head and neck cancer surgeries during the COVID-19 pandemic, created by the MD Anderson Head and Neck Surgery Treatment Guidelines Consortium. The guidelines cover multiple cancer subsites and provide alternative treatment options for deferred surgeries. They are intended to help clinicians allocate resources during a healthcare crisis.

Use Cases

• Analyzing triage recommendations for head and neck cancer surgeries based on subsite-specific guidance.
• Studying alternative treatment modalities for surgical oncology when resources are limited.
• Modeling clinical decision-making frameworks for resource allocation during healthcare crises.

Strengths

• Created by a consortium of experts from a leading cancer center, The University of Texas MD Anderson Cancer Center.
• Covers multiple head and neck cancer subsites including aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

The University of Texas MD Anderson Cancer Center

Collection Method

Multidisciplinary consensus guidelines devised by the MD Anderson Head and Neck Surgery Treatment Guidelines Consortium.

Time Range

COVID-19 pandemic period